Company details
Nucs AI
Medical AI software for tumor detection, treatment prediction and response monitoring in molecular imaging.
Stability signals
- CEO
- Nijat Ahmadov
- Founders
- Nijat Ahmadov, Farid Yagubbayli
- Total raised
- $3.5M
- Founders' prior
companies - Unknown
- Recent evidence
Strategic Investment And Partnership · Nucs AI and Segmed announced a strategic oncology-data partnership including a Segmed investment in Nucs AI of undisclosed amount.
Scope: Nucs AI oncology/theranostics company associated with nucs.ai; no specific cash receipt by Berlin or Munich subsidiary.
Evidence reviewed 2026-10-24. This claim does not establish overall financial stability.
Verified 2026-10-07
At a glance
Open roles
1
activeNew this month
0
New openings
1
opened in the last 90 daysGerman requirement
0%
based on 1 of 1 rolesOpen roles over time
Open roles · 12 months
1open
2025-12 → 2026-11Month-end counts · Nov shows current open roles
1 open roles
- Remote job, Berlin, Munich, Boston, Toronto, Prague, Paris, New York, London
- 0
- Berlin, Berlin, Germany, Munich
- 1